Related Experiment Video
Updated: Jan 17, 2026
07:20
Inducement and Evaluation of a Murine Model of Experimental Myopia
Published on: January 22, 2019
10.5K
Methylphenidate Inhibits the Development of Myopia by Altering Dopamine and Norepinephrine Reuptake
Cindy Karouta1, Kate Thomson1, Ian Morgan2
1Biomedical Science, Faculty of Science and Technology, University of Canberra, Bruce, Canberra, Australian Capital Territory, Australia.
Investigative Ophthalmology & Visual Science
|September 23, 2025
Summary
Methylphenidate hydrochloride (MPH) effectively inhibits myopia progression in chicks by increasing dopamine and norepinephrine levels. This supports the role of these neurotransmitters in regulating eye growth and myopia development.
Area of Science:
- Ophthalmology
- Neuroscience
- Pharmacology
Background:
- Dopaminergic dysregulation is implicated in myopia development in animal models.
- Methylphenidate hydrochloride (MPH), a dopamine (DA) and norepinephrine (NE) uptake inhibitor, shows promise in slowing myopia progression in children.
Purpose of the Study:
- To investigate MPH's efficacy in inhibiting myopic growth in an animal model.
- To elucidate the underlying mechanisms of MPH's anti-myopic effects.
Main Methods:
- MPH was administered orally, topically, or intravitreally to chicks with form-deprivation myopia (FDM).
- Retinal DA and NE dynamics were assessed using mass spectrometry and chronoamperometry.
- DA and NE receptors were blocked to determine their role in MPH's effects.
Main Results:
- MPH significantly inhibited FDM across all administration routes.
- MPH enhanced DA and NE synthesis and blocked their uptake, increasing extracellular levels.
- Blocking DA or NE receptors abolished MPH's anti-myopic effects; NE receptor stimulation alone inhibited FDM.
Conclusions:
- MPH suppresses experimental myopia by increasing extracellular DA and NE levels.
- Findings support a role for DA in human myopia and suggest NE also regulates ocular growth.
Related Concept Videos
01:29Drugs Affecting Neurotransmitter Synthesis
2.1K
Drugs affecting neurotransmitter synthesis can impact the adrenergic neuron and the synthesis of neurotransmitters. For example, α-methyltyrosine and carbidopa target specific enzymes involved in catecholamine synthesis. α-methyltyrosine inhibits the enzyme tyrosine hydroxylase, which converts tyrosine into dopamine. By blocking this enzyme, α-methyltyrosine reduces dopamine production and other catecholamines. Carbidopa, on the other hand, inhibits the enzyme dopa decarboxylase,...
2.1K
01:25Adrenergic Agonists: Indirect-Acting Agents
2.6K
Indirect-acting adrenergic agonists potentiate the effects of endogenous catecholamines through different mechanisms without directly binding to adrenoceptors.
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
One mechanism involves depleting stored catecholamines by displacing them from synaptic vesicles. These agents, known as "displacers," are transported into vesicles at the expense of noradrenaline. Examples include amphetamine and tyramine, which lack a catechol moiety, resulting in prolonged action, improved oral...
2.6K
01:21Drugs Affecting Neurotransmitter Release or Uptake
1.5K
Certain drugs can affect how neurotransmitters called catecholamines, are released or taken back up in the adrenergic neuron. They can have different effects on the body's sympathetic transmission. Reserpine, a natural compound found in the Rauwolfia shrub, blocks a transporter called vesicular monoamine transporter (VMAT), which leads to a buildup of catecholamines in the cell and reduces sympathetic transmission. Another drug called guanethidine works in multiple ways, including blocking...
1.5K
01:30Attention-Deficit/Hyperactivity Disorder
787
Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings....
787
01:28Adrenergic Agonists: Mixed-Action Agents
1.4K
Mixed-action adrenergic agonists, like ephedrine and pseudoephedrine, directly and indirectly affect adrenergic receptors. These agents stimulate adrenoceptors and indirectly release stored neurotransmitters, amplifying the adrenergic response.
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
Ephedrine and pseudoephedrine lack a catecholamine group, making them less susceptible to degradation by metabolic enzymes. They have increased oral bioavailability and lipophilicity, resulting in a longer duration of action. Their response is reduced by...
1.4K
01:24Antiasthma Drugs: Methylxanthines
1.6K
Theophylline, a member of the methylxanthine class of bronchodilators, has long been used in asthma management. While its exact mechanism of action is not fully understood, it is believed to have multiple effects on various cellular processes.
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
Theophylline is thought to inhibit phosphodiesterase enzymes, increasing intracellular levels of cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP). This rise in cAMP and cGMP concentrations stimulates cardiac function,...
1.6K